Detecting RET Oncogene Activation in Thyroid Cancer
Author Information
Author(s): N. Fabien, C. Paulin, M. Santoro, N. Berger, M. Grieco, D. Galvain, Y. Barbier, P.M. Dubois, A. Fusco
Hypothesis
Can in situ hybridization effectively detect RET oncogene activation in human papillary thyroid carcinomas?
Conclusion
The study demonstrates that RET activation can be detected in papillary thyroid carcinomas using in situ hybridization.
Supporting Evidence
- Four out of ten papillary carcinomas showed activated RET transcripts.
- Normal thyroid tissues and non-papillary carcinomas did not show RET transcripts.
- ISH technique allows detection of RET activation in single cells.
Takeaway
Scientists found a way to see if a specific gene is active in thyroid cancer cells, which helps understand the cancer better.
Methodology
In situ hybridization was used to detect RET transcripts in thyroid tissue samples.
Limitations
The study did not analyze all types of thyroid tissues and focused only on specific carcinoma types.
Participant Demographics
Included 5 normal thyroids, 7 adenomatous goiters, and 15 thyroid carcinomas.
Want to read the original?
Access the complete publication on the publisher's website